Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nihon Nohyaku Co. Ltd.

Latest From Nihon Nohyaku Co. Ltd.

Topica nails down $27 million Series B in pursuit of fungal infection treatment

While the yellow-green fungus that infects toenails, known as onychomycosis, may not be a sexy topic of discussion, the potential multibillion market for a drug to fill the current unmet need was enough of an alluring siren call to entice investors to lay down a bundle of cash to back Topica Pharmaceuticals' development of its experimental broad-spectrum topical antifungal agent luliconazole to treat the condition.

Infectious Diseases Japan

Ranbaxy markets Summit's luliconazole in India

Ranbaxy Laboratories has launched the antifungal luliconazole (marketed as Lulifin) in India. The product is licensed from Japan's Summit Pharmaceuticals International Corporation (SPI).


Topica Pharmaceuticals

Topica began its life with a promising novel anti-fungal called luliconazole (Lulicon) in hand. The compound was developed by Nihon Nohyaku and is already approved in Japan for tinea infections. Topica's initial focus will be on advancing ongoing clinical trials of the drug in athlete's foot, but even as it begins studies in athlete's foot, a market IMS estimates to be approximately $400 million in the US alone, the end goal is a topical treatment for onychomycosis.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Nihon Nohyaku Co. Ltd.
  • Senior Management
  • Toshikazu Murata, Chmn.
    Shukichi Ohuchi, Pres.
  • Contact Info
  • Nihon Nohyaku Co. Ltd.
    Phone: (81) 3 327 43374
    1-2-5 Nihonbashi
    Tokyo, 103-8236